NEW YORK (GenomeWeb News) – Transgenomic yesterday said that it has signed a licensing option agreement with Gene Solutions for a set of validated mutations that can form the basis of a diagnostic test for Parkinson's disease.

Under the agreement, the companies will evaluate the ability of Transgenomic's mitochondrial mutation-detection technology to detect and quantify the presence of the mutations – low-level mitochondrial DNA, or mtDNA, variants that have been shown to be present in Parkinson's disease patients but rarely in age-matched control individuals.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers describe a way to share data while keeping it secure, Agence France Presse reports.

In Science this week: genetic mutations typically associated with esophageal cancer are common in older, healthy individuals, and more.

India's Council of Scientific and Industrial Research has a new director-general, according to ScienceInsider.

A new study links more than a hundred genes to autism spectrum disorder, Discover's D-brief blog reports.

Oct
23
Sponsored by
PerkinElmer

This webinar will address a range of methods for optimizing small RNA library preparation.

Nov
05
Sponsored by
Sophia Genetics

With the Next Generation Sequencing (NGS), genomes sequencing has been democratized over the last decades with the detection of genomic alterations, thus replacing Sanger sequencing.

Nov
29
Sponsored by
Schott

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.